Skip to main content

ARONAMIN GOLD

Medically reviewed by Drugs.com. Last updated on Dec 2, 2020.

Dosage form: tablet, film coated
Ingredients: RIBOFLAVIN TETRABUTYRATE 2.5mg, FURSULTIAMINE 50mg, HYDROXOCOBALAMIN ACETATE 5.22ug, .ALPHA.-TOCOPHEROL ACETATE 20mg, ASCORBIC ACID 70mg
Labeler: OASIS TRADING
NDC Code: 72689-0024

Fursultiamine(Active vitamin B1) 50.0mg
Riboflavin tetrabutyrate(Active vitamin B2) 2.5mg
Pyridoxal phosphate(Active vitamin B6) 2.5mg
Hydroxocobalamin acetate(Active vitamin B12) 5.22μg
Ascorbic acid(Vitamin C) 70mg
Tocopheryl acetate(Vitamin E) 20.0mg

Vitamines, Mineral & nutrients

Keep out of reach of children

Adults: take 1 tablet twice a day.

1) Do not take this medicine.

(1) Patients with hypersensitivity reactions to NSAIDs and the components contained in NSAIDs

(2) Infants under three months of age

(3) Because this drug contains lactose, patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption Do not administer.

2) Do not take the following medicine while taking this medicine.

(1) levodopa

3) Consult a doctor, dentist or pharmacist before taking this medicine.

(1) Patients receiving medical treatment

(2) patients with hyperoxaluria (excessive urinary excretion of urine)

(3) Pregnant women and possibly pregnant women, lactating women, premature infants, infants

(4) Patients with gout or kidney stones

4) Stop taking this drug immediately and consult a doctor, dentist, or pharmacist if you: Whenever possible, bring this attached document with you.

(1) If you have any of the following symptoms

Stomach discomfort, diarrhea, constipation, rash, fever, nausea, vomiting, dilated stool, stomatitis (mouth salt), anorexia, abdominal bloating

(2) Administration of this drug may result in faster or more frequent menstruation, and bleeding may last for a long time.

(3) The risk of thrombosis may be increased if a woman taking an oral contraceptive containing estrogen or a patient with thrombotic placenta is taking vitamin E.

(4) Long-term administration of high doses may result in resistance.

(5) Prolonged use of pyridoxine at a dose of 500 mg to 2 g / day may result in neuropathy or neuropathy (functional disorder or pathologic changes) in the peripheral nervous system.

(6) Hematologic adverse events may occur when vitamin B12 is administered at a dose of 10 μg or more per day in patients with insufficient folic acid.

5) Other Precautions for Taking

(1) Keep the prescribed dosage and dosage.

(2) it may interfere with the detection of blood glucose during various urine tests

(3) The urine may turn yellow, which may affect the clinical examination

6) Storage Precautions

(1) Keep out of the reach of children.

(2) Avoid direct sunlight. Store in a cool, dry place.

(3) To prevent misuse (misuse) and to preserve quality, please do not put in another container.

Microcrystalline Cellulose, Magnesium Stearate, Crospovidone, Copovidone, Colloidal Silicon Dioxide, OY-25014, OY-S-29019

For oral use only

ARONAMIN GOLD 
fursultiamine, riboflavin tetrabutyrate, pyridoxal phosphate, hydroxocobalamin acetate, ascorbic acid, tocopheryl acetate tablet, film coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72689-0024
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RIBOFLAVIN TETRABUTYRATE (RIBOFLAVIN TETRABUTYRATE) RIBOFLAVIN TETRABUTYRATE2.5 mg
FURSULTIAMINE (FURSULTIAMINE) FURSULTIAMINE50 mg
HYDROXOCOBALAMIN ACETATE (HYDROXOCOBALAMIN) HYDROXOCOBALAMIN5.22 ug
.ALPHA.-TOCOPHEROL ACETATE (.ALPHA.-TOCOPHEROL) .ALPHA.-TOCOPHEROL ACETATE20 mg
ASCORBIC ACID (ASCORBIC ACID) ASCORBIC ACID70 mg
Inactive Ingredients
Ingredient NameStrength
LACTOSE MONOHYDRATE (ANHYDROUS LACTOSE)  
MAGNESIUM STEARATE 
MICROCRYSTALLINE CELLULOSE 
COPOVIDONE K25-31 
SILICON DIOXIDE 
CROSPOVIDONE 
Product Characteristics
ColorredScoreno score
ShapeOVALSize16mm
FlavorImprint CodeAroG
Contains    
Packaging
#Item CodePackage Description
1NDC:72689-0024-1100 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/20/2018
Labeler - OASIS TRADING (689991468)
Registrant - OASIS TRADING (689991468)
Establishment
NameAddressID/FEIOperations
OASIS TRADING689991468manufacture(72689-0024), label(72689-0024)

 
OASIS TRADING

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.